000			01583 a2200457 4500
005			20250513121659.0
264		0	_c19970721
008			199707s 0 0 eng d
022			_a1098-4275
024	7		_a10.1542/peds.100.1.65 _2doi
040			_aNLM _beng _cNLM
100	1		_aHalperin, S A
245	0	0	_aSeven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. _h[electronic resource]
260			_bPediatrics _cJul 1997
300			_a65-71 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aAntibodies, Bacterial _xanalysis
650	0	4	_aBordetella pertussis _ximmunology
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aErythromycin Estolate _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin A _xanalysis
650	0	4	_aImmunoglobulin G _xanalysis
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aNasopharynx _xmicrobiology
650	0	4	_aTime Factors
650	0	4	_aWhooping Cough _xdiagnosis
700	1		_aBortolussi, R
700	1		_aLangley, J M
700	1		_aMiller, B
700	1		_aEastwood, B J
773	0		_tPediatrics _gvol. 100 _gno. 1 _gp. 65-71
856	4	0	_uhttps://doi.org/10.1542/peds.100.1.65 _zAvailable from publisher's website
999			_c9180876 _d9180876